Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

Clinical trial NCT06447376 · RECRUITING

Trial details

NCT number: NCT06447376
Sponsor: Taylor Brooks
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma Cytokine Release Syndrome

Start date: 2025-01-14
Primary completion: 2028-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.